29 March 2024, Friday, 9:46
Support
the website
Sim Sim,
Charter 97!
Categories

Ukrainian Medicines Disappear From Belarusian Pharmacies

7
Ukrainian Medicines Disappear From Belarusian Pharmacies

There are brands that have no analogues in our country.

In recent months, dozens of medications have disappeared from Belarusian pharmacies. A significant market share was occupied by Ukrainian manufacturers. But after the start of a full-scale war between Russia and Ukraine, in which the Lukashenka regime took the side of the aggressor, any cooperation came to naught, writes euroradio.fm.

Manufacturers are recalling drugs

Any medicine must be registered and included in the relevant register in order to be used and sold in Belarus. However, registration is not carried out when the Ministry of Health considers it necessary to include certain medicine in the register — on the contrary, it’s the manufacturer (or supplier) that must apply with a corresponding request.

The company may also withdraw its application for registration. This is what several major Ukrainian drug manufacturers did after the start of the war.

Judging by the publications in the departmental journal “News of expertise and registration”, in May the Ministry of Health decided to terminate the registration of the products of the Darnitsa plant, including Analgin, Captopres, Septefril, and other drugs produced by the enterprise.

A month later, in June, the registration applications were withdrawn by another major Ukrainian manufacturer, Farmak. Among their drugs are Validol, Tramadol, and Rheumoxicam.

Some manufacturers have either not yet initiated a formal drug recall process or are not yet aware of it. For example, pharmacies are running out of Kyivmedpreparaty medicines, including the antidepressant Fluxen, which cannot be stopped abruptly and has no analogues in Belarus. The same thing happened with the blood pressure reducing drug Raunatin, which was produced by the Ukrainian company Zdorovye. There are no analogues in our market.

Not only patients, but also money

It’s patients who will suffer the most without medications, especially those who need the preparations that have no analogues so far. However, the withdrawal of registration or a banal suspension in the supply of drugs is not a good signal for the economy either.

Judging by the Intellix database, over 1.3 million packs of the same Corvalol from Farmak were sold in 2021, which is more than 350 thousand euros in wholesale prices. Tomohexol from the same manufacturer at wholesale prices for 2021 was sold for almost half a million euros.

In general, sales of medicines from Ukrainian manufacturers amounted to tens of millions of euros. Of course, now producers will not have this income, but Belarus will also receive less taxes, suppliers will not earn money further down the chain.

Although the Ministry of Health reports that there are no problems with medications in general in Belarus, Belarusians ask questions about the disappearance of certain drugs.

Write your comment 7

Follow Charter97.org social media accounts